- Home
- DHR vs TMO Comparison
DHR vs TMO Comparison
Compare DHR & TMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DHR
- TMO
- Stock Information
- Founded
- DHR 1969
- TMO 1956
- Country
- DHR United States
- TMO United States
- Employees
- DHR N/A
- TMO N/A
- Industry
- DHR Industrial Machinery/Components
- TMO Industrial Machinery/Components
- Sector
- DHR Industrials
- TMO Industrials
- Exchange
- DHR Nasdaq
- TMO Nasdaq
- Market Cap
- DHR 180.6B
- TMO 211.0B
- IPO Year
- DHR N/A
- TMO N/A
- Fundamental
- Price
- DHR $233.10
- TMO $512.92
- Analyst Decision
- DHR Buy
- TMO Strong Buy
- Analyst Count
- DHR 17
- TMO 19
- Target Price
- DHR $287.12
- TMO $651.56
- AVG Volume (30 Days)
- DHR 3.0M
- TMO 1.7M
- Earning Date
- DHR 10-22-2024
- TMO 10-23-2024
- Dividend Yield
- DHR 0.46%
- TMO 0.30%
- EPS Growth
- DHR N/A
- TMO 4.56
- EPS
- DHR 5.24
- TMO 15.95
- Revenue
- DHR $23,742,000,000.00
- TMO $42,370,000,000.00
- Revenue This Year
- DHR $0.38
- TMO $0.84
- Revenue Next Year
- DHR $5.88
- TMO $5.38
- P/E Ratio
- DHR $44.44
- TMO $32.15
- Revenue Growth
- DHR 12.92
- TMO N/A
- 52 Week Low
- DHR $215.68
- TMO $480.57
- 52 Week High
- DHR $281.70
- TMO $627.88
- Technical
- Relative Strength Index (RSI)
- DHR 30.12
- TMO 28.16
- Support Level
- DHR $228.25
- TMO $493.30
- Resistance Level
- DHR $252.94
- TMO $570.20
- Average True Range (ATR)
- DHR 4.81
- TMO 12.73
- MACD
- DHR -0.71
- TMO -3.14
- Stochastic Oscillator
- DHR 19.62
- TMO 25.51
About DHR Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life science and diagnostic industries after the late 2023 divesititure of its environmental and applied solutions group, Veralto.
About TMO Thermo Fisher Scientific Inc
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (22%); and lab products and services, which includes CRO services (54%).